All the news Showing 10 of 14 articles from: Hepatitis C eliminationGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources What are the barriers to hepatitis C treatment in prisons? Keith Alcorn / 15 October 2018 Lack of privacy, lack of peer support and lack of harm reduction are perceived as the biggest barriers to improving the uptake of direct-acting antiviral treatment for hepatitis C among prisoners, a qualitative ... Hepatitis C elimination in people living with HIV in the UK is feasible by 2021, British HIV Association says Keith Alcorn / 10 October 2018 Hepatitis C co-infection can be eliminated in people living with HIV in the United Kingdom by 2021, the British HIV Association (BHIVA) said today. “The UK can be the first country to achieve ... Hepatitis C elimination in people who inject drugs needs a health system strategy, says expert review Keith Alcorn / 24 September 2018 Achieving the elimination of hepatitis C in people who inject drugs will require a comprehensive health system-wide strategy that addresses stigma, barriers to care, financing, the involvement of people who inject drugs and ... Deaths from end-stage liver disease due to HCV fall in United Kingdom Keith Alcorn / 22 August 2018 Deaths from end-stage liver disease and liver cancer caused by hepatitis C in the United Kingdom fell by 11% in 2017, provisional figures from Public Health England released on 28 July show. Most ... Scotland’s reduction in new HCV infections due to harm reduction, not treatment Keith Alcorn / 12 June 2018 The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and ... Georgia: 98% cured of hepatitis C Keith Alcorn / 23 May 2018 Georgia is making strong progress towards eliminating hepatitis C but will need triple the number of people starting treatment if it is to reach its national elimination target of a ... HCV treatment feasible and effective in sub-Saharan Africa Keith Alcorn / 17 April 2018 A 12-week course of sofosbuvir/ledipasvir proved highly effective in a sub-Saharan African setting, results of a study carried out in Rwanda show. The findings were presented on Friday at the ... Active invitation to test for viral hepatitis greatly improves uptake of testing among South Asians in England Keith Alcorn / 16 April 2018 Inviting migrants and their children by post to test for hepatitis B and C in primary care settings results in the identification of a high prevalence of previously undiagnosed infections, ... Australian experience shows that use of DAAs can virtually eliminate HCV among prisoners Michael Carter / 19 March 2018 Hepatitis C virus (HCV) infection can be rapidly eliminated in prison populations with the use of direct-acting antivirals (DAAs), results of an Australian study published in Clinical Infectious Diseases suggests. ... Harm reduction scale-up needed to eliminate HCV in people who inject drugs, European model predicts Keith Alcorn / 01 February 2018 Elimination of hepatitis C among people who inject drugs in Europe will require simultaneous scale-up of direct-acting antiviral treatment, needle and syringe programmes (NSP) and opioid substitution therapy (OST), and ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Noticeboard Email bulletins News feeds